HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eduardo Slatopolsky Selected Research

paricalcitol (Zemplar)

11/2017Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
6/2015Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.
1/2014Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats.
1/2012Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats.
7/2010Myocardial effects of VDR activators in renal failure.
6/2010Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
1/2009Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats.
6/2003New vitamin D analogs.
6/2003Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eduardo Slatopolsky Research Topics

Disease

28Secondary Hyperparathyroidism
11/2017 - 01/2002
14Chronic Renal Insufficiency
11/2017 - 01/2004
14Hyperplasia
04/2011 - 04/2002
13Uremia
06/2015 - 06/2003
13Chronic Kidney Failure (Chronic Renal Failure)
01/2011 - 01/2002
12Vascular Calcification
12/2013 - 11/2001
8Hyperphosphatemia
06/2015 - 01/2002
8Renal Insufficiency (Renal Failure)
06/2007 - 10/2000
7Hypercalcemia (Milk Alkali Syndrome)
02/2007 - 01/2002
5Kidney Diseases (Kidney Disease)
01/2013 - 11/2005
5Bone Resorption
12/2002 - 10/2000
4Fibrosis (Cirrhosis)
01/2014 - 09/2002
4Bone Diseases (Bone Disease)
02/2007 - 05/2002
3Hyperparathyroidism
11/2017 - 12/2002
3Cardiovascular Diseases (Cardiovascular Disease)
01/2016 - 08/2005
3Proteinuria
01/2014 - 11/2003
3Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
01/2013 - 01/2003
2Hypocalcemia
06/2010 - 01/2004
2Neoplasms (Cancer)
07/2005 - 10/2002
2Osteitis
01/2004 - 01/2003
1Inflammation (Inflammations)
12/2013
1Hypertension (High Blood Pressure)
01/2013
1Heart Diseases (Heart Disease)
07/2010
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
07/2010
1Magnesium Deficiency (Deficiency, Magnesium)
11/2009
1Infections
07/2009
1Hypertrophy
01/2009
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2008
1Autoimmune Diseases (Autoimmune Disease)
07/2005
1Vitamin D Deficiency
07/2005
1Pruritus (Itching)
12/2004
1Nephrocalcinosis
11/2003

Drug/Important Bio-Agent (IBA)

16CalciumIBA
01/2009 - 01/2002
14Calcitriol (Calcijex)FDA LinkGeneric
11/2017 - 01/2002
14Phosphates (Orthophosphate)IBA
01/2016 - 01/2002
14Vitamin DFDA LinkGeneric
06/2012 - 01/2002
131,25-dihydroxyvitamin DIBA
06/2010 - 10/2000
12Phosphorus (Red Phosphorus)IBA
01/2011 - 01/2002
12Parathyroid Hormone (Parathormone)IBA
02/2007 - 10/2000
9paricalcitol (Zemplar)FDA Link
11/2017 - 06/2003
7calcium phosphateIBA
07/2009 - 11/2001
6Proteins (Proteins, Gene)FDA Link
01/2010 - 11/2001
6Transforming Growth Factor alpha (TGF-alpha)IBA
10/2008 - 10/2002
5EnalaprilFDA LinkGeneric
01/2014 - 01/2009
5CreatinineIBA
01/2014 - 11/2003
5Sevelamer (RenaGel)FDA Link
12/2013 - 09/2002
5MineralsIBA
01/2013 - 06/2003
4ErbB Receptors (EGF Receptor)IBA
04/2011 - 01/2004
4Proliferating Cell Nuclear Antigen (PCNA)IBA
07/2010 - 11/2005
4Calcitriol Receptors (Calcitriol Receptor)IBA
07/2009 - 01/2003
3Cinacalcet (Sensipar)FDA Link
11/2017 - 02/2007
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2012 - 06/2007
3hydroxide ionIBA
06/2003 - 10/2000
2Transforming Growth Factors (Transforming Growth Factor)IBA
04/2011 - 04/2011
2Messenger RNA (mRNA)IBA
07/2009 - 02/2008
2alpha-2-HS-GlycoproteinIBA
07/2009 - 01/2009
2Calcium-Sensing ReceptorsIBA
07/2009 - 12/2002
2LigandsIBA
11/2005 - 10/2002
2maxacalcitolIBA
12/2004 - 06/2003
2Calcium Carbonate (Limestone)FDA Link
11/2003 - 09/2002
1AtrasentanIBA
01/2014
1Peroxidase (Myeloperoxidase)IBA
01/2012
1Superoxide DismutaseIBA
01/2012
1Glutathione PeroxidaseIBA
01/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2012
1C-Reactive ProteinIBA
01/2011
1sodium thiosulfateFDA Link
01/2011
1FetuinsIBA
01/2011
1Cyclin D2IBA
01/2010
1MagnesiumIBA
11/2009
1Calcifediol (Calcidiol)FDA Link
07/2009
1Small Interfering RNA (siRNA)IBA
07/2009
1OsteopontinIBA
07/2009
1Collagenases (Collagenase)FDA Link
07/2009
1MitogensIBA
02/2008
1Staphylococcal Protein A (Protein A)IBA
02/2008
1Transcription Factors (Transcription Factor)IBA
02/2008
1Protein Isoforms (Isoforms)IBA
02/2008
1CCAAT-Enhancer-Binding Protein-betaIBA
02/2008
1Transforming Growth Factor beta (TGF-beta)IBA
06/2007
1Therapeutic UsesIBA
05/2007
12-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferolIBA
05/2007
1Pharmaceutical PreparationsIBA
02/2007
1BuffersIBA
02/2007
1CarbonatesIBA
12/2005
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2005
1AluminumIBA
08/2005
1Trans-Activators (Trans-Acting Factor)IBA
05/2004
1SterolsIBA
05/2004
1Retinoid X Receptors (Retinoid X Receptor)IBA
01/2004
1Uremic ToxinsIBA
01/2004
1Cholecalciferol (Vitamin D3)FDA Link
06/2002
1alfacalcidolIBA
06/2002
1Dietary PhosphorusIBA
04/2002

Therapy/Procedure

11Therapeutics
01/2014 - 06/2002
3Renal Dialysis (Hemodialysis)
01/2011 - 12/2004
3Nephrectomy
06/2010 - 01/2002
1Parathyroidectomy
11/2017